Potential Therapeutic Targets and Promising Agents for Combating NAFLD

Ítems similars

• Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis
  per: Okuda, Keiichiro, et al.
  Publicat: (2021)
• The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
  per: Yuya Seko, et al.
  Publicat: (2020-10-01)
• The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
  per: Seko, Yuya, et al.
  Publicat: (2020)
• The Effect of Genetic Polymorphism in Response to Body Weight Reduction in Japanese Patients with Nonalcoholic Fatty Liver Disease
  per: Seko, Yuya, et al.
  Publicat: (2021)
• FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease
  per: Seko, Yuya, et al.
  Publicat: (2019)